Phase I/Ii, Multicenter, Open-Label, Dose-Escalation Study Of Bendamustine In Combination With Lenalidomide And Dexamethasone (Brd) In Patients With Relapsed Multiple Myeloma: A Multiple Myeloma Research Consortium Study

BLOOD(2012)

引用 24|浏览13
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要